Managing colorectal cancer liver metastases

ONCOLOGY

Volumn 23, Issue 12, 2009, Pages

  Wagman, Lawrence D ^a   Byun, Timothy E ^a  

^a ST JOSEPH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CAPECITABINE; CETUXIMAB; FLOXURIDINE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN; PANITUMUMAB;

CANCER CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; COLORECTAL CANCER; COMORBIDITY; CONSULTATION; HEPATITIS; HUMAN; LIVER INJURY; LIVER METASTASIS; LIVER NODULE; LIVER RESECTION; MEDICAL DECISION MAKING; MULTIPLE CYCLE TREATMENT; ONLINE SYSTEM; RADIOFREQUENCY ABLATION; RECURRENT DISEASE; REVIEW; RISK FACTOR; STEATOSIS; SURGICAL TECHNIQUE; VASCULAR LESION;

EID: 72449176975     PISSN: 08909091     EISSN: 08909091     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. Jaffe CC: Measures of response: RECIST, WHO, and new alternatives. J Clin Oncol 24:3245-3325, 2006.
2. Vauthey JN, Abdalla E, Doherty D, et al: Body surface area and body weight predict total liver volume in Western adults. Liver Transpl 8:233-240, 2002. (Pubitemid 34257205)
3. Capussotti L, Muratore A, Baracchi F, et al: Portal vein ligation as an efficient method of increasing the future liver remnant volume in the surgical treatment of colorectal metastases. Arch Surg 143:978-982, 2008.
4. Feliberti E, Wagman LD: Radiofrequency ablation of liver metastases from colorectal carcinoma. Cancer Control 13:48-51, 2006. (Pubitemid 43327554)
5. Adam R, Delvart V, Pascal G, et al: Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: A model to predict long-term survival. Ann Surg 240:644-658, 2004.
6. Charnsangavej C, Clary B, Fong Y, et al: Selection of patients for resection of hepatic colorectal metastases: Expert consensus statement. Ann Surg Oncol 13:1261-1268, 2006. (Pubitemid 44435791)
7. Mann C, Metcalfe M, Leopardi L, et al: The clinical risk score: Emerging as a reliable preoperative prognostic index in hepatectomy for colorectal metastases. Arch Surg 139:1168-1172, 2004. (Pubitemid 39463447)
8. Yasui K, Hirai T, Kato T, et al: A new macroscopic classification predicts prognosis for patient with liver metastases from colorectal cancer. Ann Surg 226:582-586, 1997. (Pubitemid 28049653)
9. Kattan M, Gönen M, Jarnagin W, et al: A nomogram for predicting disease-specific survival after hepatic resection for metastatic colorectal cancer. Ann Surg 247:282-287, 2008. (Pubitemid 351156771)
10. Laurent C, Sa Cunha A, Rullier E, et al: Impact of microscopic hepatic lymph node involvement on survival after resection of colorectal liver metastasis. J Am Coll Surg 198:884-891, 2004. (Pubitemid 38759838)
11. Jaeck D, Nakano H, Bachellier P, et al: Significance of hepatic pedicle lymph node involvement in patients with colorectal liver metastases: A prospective study. Ann Surg Oncol 9:430-438, 2002. (Pubitemid 34625801)
12. Adam R, de Haas R, Wicherts D, et al: Is hepatic resection justified after chemotherapy in patients with colorectal liver metastases and lymph node involvement? J Clin Oncol 26:3672-3680, 2008.
13. Wagman LD: Expanded criteria for surgery for liver metastases: Thoughtful science or diamond mining? J Clin Oncol 26:3663-3664, 2008.
14. Minagawa M, Yamamoto J, Miwa S, et al: Selection criteria for simultaneous resection in patients with synchronous liver metastasis. Arch Surg 141:1006-1012, 2006. (Pubitemid 44583259)
15. Martin R, Paty P, Fong Y, et al: Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis. J Am Coll Surg 197:233-241, 2003. (Pubitemid 36927386)
16. Benoist S, Brouquet A, Penna C, et al: Complete response of colorectal liver metastases after chemotherapy: Does it mean cure? J Clin Oncol 24:3939-3945, 2006.
17. Tournigand C, André T, Achille E, et al: FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced in advanced colorectal cancer: A randomized GERCOR study. J Clin Oncol 22:229-237, 2004. (Pubitemid 41095086)
18. Hurwitz H, Fehrenbacher L, Novotny W, et al: Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350:2335-2342, 2004. (Pubitemid 38702844)
19. Saltz LB, Clarke S, Díaz-Rubio E, et al: Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: A randomized phase III study. J Clin Oncol 26:2013-2019, 2008.
20. Fuchs CS, Marshall J, Mitchell E, et al: Randomized, controlled trial of irinotecan plus infusional, bolus, or oral fluoropyrimidines in first-line treatment of metastatic colorectal cancer: Results from BICC-C study. J Clin Oncol 25:4779-4786, 2007. (Pubitemid 350086481)
21. Van Cutsem E, Köhne CH, Hitre E, et al: Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer. N Engl J Med 360:1408-1417, 2009.
22. Kooby DA, Fong Y, Suriawinata A, et al: Impact of steatosis on perioperative outcome following hepatic resection. J Gastrointest Surg 7:1034-1044, 2003. (Pubitemid 37524071)
23. Aloia T, Sebagh M, Plasse M, et al: Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases. J Clin Oncol 24:4983-4990, 2006. (Pubitemid 46631400)
24. Vauthey JN, Pawlik TM, Ribero D, et al: Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 24:2065-2072, 2006. (Pubitemid 46622116)
25. Nordlinger B, Sorbye H, Glimelius B, et al: Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): A randomized controlled trial. Lancet 371:1007-1016, 2008.
26. Bilchik A, Hecht JR: Perioperative risks of bevacizumab and other biologic agents for hepatectomy: Theoretical or evidence based? J Clin Oncol 26:1786-1788, 2008.
27. Mitry E, Fields A, Bleiberg H, et al: Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer: A pooled analysis of two randomized trials. J Clin Oncol 26:4906-4911, 2008.
28. Kemeny NE, Gonen M: Hepatic artery infusion after liver resection. N Engl J Med 352:734-735, 2005.
29. Kemeny MM, Adak S, Gray B, et al: Combined modality treatment for resectable metastatic colorectal carcinoma to the liver: Surgical resection of hepatic metastases in combination with continuous infusion of chemotherapyan intergroup study. J Clin Oncol 20:1499-1505, 2002. (Pubitemid 34260528)